Revance

Revance

Biotechnology Research

Nashville, Tennessee 29,840 followers

About us

Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that elevate patient and physician experiences.

Industry
Biotechnology Research
Company size
501-1,000 employees
Headquarters
Nashville, Tennessee
Type
Public Company
Specialties
Botulinum Toxin, biotechnology, biotech, healthcare, pharmaceuticals, science, research, financial services, and fintech

Locations

Employees at Revance

Updates

  • View organization page for Revance, graphic

    29,840 followers

    It’s the 2nd anniversary of the award-winning #DAXXIFY and we have so much to celebrate! 🎉 First and only peptide-powered frown line treatment. 🎉 The benefits are clear: Fast. Lasts. And the Look. 🎉 More and more awards! We can’t wait for more to come with your continued support. See what’s to love about DAXXIFY® at daxxify.com #Cheers2Daxxify #RVNC #SettingtheNewStandard Results as early as the next day and typically within 2 days. At least 50% of patients in clinical studies had no or minor frown lines 6 months after treatment. Improves the appearance of skin texture versus before treatment. 64% of patients achieved an improvement in the appearance of skin texture at week 2 from a post hoc analysis of a Phase 2 clinical study with 60 patients. For DAXXIFY® Full Prescribing Information including Boxed Warning and Medication Guide, seehttps://lnkd.in/etBtYw-S. DAXXIFY®(daxibotulinumtoxinA-Ianm) is a prescription medicine for adults to temporarily improve the look of moderate to severe frown lines between the eyebrows. Ask your doctor to tell you about DAXXIFY®. DAXXIFY® may cause serious side effects hours to weeks after injection. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems or muscle weakness can be a sign of a life-threatening condition. The most common side effects are headache, eyelid drooping, and loss of the ability to move some muscles in your face. Call your doctor for medical advice about side effects. Intended for US audiences. From TIME. ©2023 TIME USA LLC. All rights reserved. Used under license

  • View organization page for Revance, graphic

    29,840 followers

    It’s the four-year anniversary of the #RHACollection and we’ve got so many reasons to celebrate! We’ve just hit a major milestone of selling more than ONE MILLION boxes of our award-winning fillers, and we continue to be the fastest growing #HyaluronicAcid filler brand in the US. Thanks a MILLION to our partner practices for embracing innovation and supporting us over the past four years. How are you celebrating RHA®? If you haven’t tried the RHA® Collection yet, now’s the time to see what the hype is all about. Learn more at rhacollection.com. #HAFiller #FillerInjections #SettingtheNewStandard #RVNC

    • No alternative text description for this image
  • View organization page for Revance, graphic

    29,840 followers

    Award winning has a nice ring to it...Thank you ELLE Magazine for recognizing #DAXXIFY and the #RHACollection as winners of the Best Treatment category for this year's Elle Tools and Treatments Awards!  For DAXXIFY® Full Prescribing Information including Boxed Warning and Medication Guide, see https://lnkd.in/etBtYw-S     DAXXIFY® (daxibotulinumtoxinA-lanm) is a prescription medicine for adults to temporarily improve the look of moderate to severe frown lines between the eye brows. Ask your doctor to tell you about DAXXIFY®. DAXXIFY® may cause serious side effects hours to weeks after injection. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems or muscle weakness can be a sign of a life-threatening condition. The most common side effects are headache, eyelid drooping, and loss of the ability to move some muscles in your face.     Call your doctor for medical advice about side effects. Intended for US audiences. 

  • View organization page for Revance, graphic

    29,840 followers

    Thank you to all who attended the 'Let’s Get Social: Social Media and Clinical Insights' education event at Revance headquarters this weekend, and thank you to Erika Barry, Libby Dysart, and Natalie Zfat for sharing your expertise! We had a great time and hope you did too! Now, who’s ready for practice integration training in August? #RevanceAesthetics #SettingtheNewStandard #RVNC Watch for Important Safety Information. For Full Prescribing Information, including Boxed Warning and Medication Guide, see https://lnkd.in/etBtYw-S DAXXIFY® (daxibotulinumtoxinA-lanm) is a prescription medicine that is injected into muscles and used to treat cervical dystonia in adults. Ask your doctor to tell you about DAXXIFY®. DAXXIFY® may cause serious side effects hours to weeks after injection. Alert your doctor right away as difficulty swallowing, speaking, and breathing due to weakening of associated muscles can be a sign of a life-threatening condition. The most common side effects are headache, injection site pain, injection site redness, muscle weakness, and upper respiratory tract infection. Call your doctor for medical advice about side effects. Intended for US audiences.

Affiliated pages

Similar pages

Browse jobs

Funding

Revance 17 total rounds

Last Round

Post IPO equity

US$ 100.0M

See more info on crunchbase